At Dolon, we specialise in strategic pricing and market access for rare disease and oncology medicines. We have up-to-the-minute knowledge of reimbursement pathways and payer requirements. We have …

Headquartered in London, Dolon has a team of 20 enthusiastic and experienced rare disease market access consultants located across Europe. While diverse in expertise, geography and language, we …

Dolon is pleased to announce the launch of the Dolon Institute, which aspires to contribute to the policy discussion that surrounds the development and availability of innovative medicines for rare and …

Consultant We are looking for a Consultant to join the Dolon team. This is a full-time role based in Dolon’s London office (near Moorgate station), with the ability to work on a hybrid basis.

Sep 19, 2025 · The Transformative Value of Cancer Medicines in Europe Prepared by Dolon Ltd for EFPIA Oncology Platform

At Dolon, our specialist knowledge in rare diseases is our greatest asset and we want to share that with our clients. We invite you to explore some examples of how we can work with you to translate our …

Home / Rare Knowledge / Publications / Dolon Institute / Dolon Institute ← Back to Dolon Institute

Dolon's Richard Dutton and Tom Kelly presented at World Evidence, Pricing and Access Congress 2025. Find the presentation here.

Dolon is an international consultancy specialising in market access and strategic pricing in rare diseases. Working in close partnership with Global and Regional teams, we help them define and …

At Dolon, our specialist knowledge in rare diseases is our greatest asset and we want to share that with our clients. We invite you to explore some examples of how we can work with you to translate our …